To determine the relative importance of TSH in white adipose tissue, we compared the adipose phenotypes of two distinct mouse models of hypothyroidism. These models differed in that the normal reciprocal relationship between thyroid hormone and TSH was intact in one and disrupted in the other. One model, thyroidectomized (THYx) mice, had a 100-fold increase in TSH and a normal TSH receptor (TSHR); in contrast, the other model, hyt/hyt mice, had a 120-fold elevation of TSH but a nonfunctional TSHR. Although both THYx and hyt/hyt mice were in a severe hypothyroid state, the epididymal fat (mg)/body wt (g) (F/B) ratio of THYx mice was much smaller than that of hyt/hyt mice (8.2 Ϯ 0.43 vs. 14.4 Ϯ 0.40, respectively, P Ͻ 0.001). The fat cell diameter in THYx mice was also smaller than that in hyt/hyt mice (79 Ϯ 2.8 vs. 105 Ϯ 2.2 m, respectively, P Ͻ 0.001), suggesting that TSH induced lipolysis in adipose tissues. When we transferred a functional mouse TSHR gene and a control plasmid into opposite sides of epididymal fat of hyt/hyt mice by plasmid injection combined with electroporation, fat weight of the TSHR side was decreased to 60% of that of the control side. Messenger RNA levels of hormonesensitive lipase in epididymal fat containing the transferred TSHR gene were twofold higher than those in tissue from the control side. These results indicated that TSH worked as a lipolytic factor in white adipose tissues, especially in mice in a hypothyroid state.
HYPOTHYROIDISM IS ASSOCIATED WITH OBESITY (14) and hyperthyroidism with weight loss (1) . Therefore, thyrotoxicosis in Graves' disease has been thought to induce weight loss, which is one major clinical indicator of this disease (2) .
In 1964, Rodbell (17) reported that thyroid-stimulating hormone (TSH) triggers lipolysis in isolated rat epididymal fat cells. Subsequently, Winand and Kohn (20) described highaffinity TSH-binding sites in guinea pig orbital tissue and TSH-induced increases in cAMP in this tissue. Later, RoselliRehfuss et al. (18) observed TSH receptor (TSHR) mRNA in adipose tissue. Additionally, we observed TSHR immunoreactivity and TSHR mRNA in nonthyroid tissues, such as retroorbital tissues, of rats (6) . We cloned TSHR cDNA from rat white adipose tissue (WAT) (7) and found that 1) adipose tissue TSHR cDNA was almost identical to that of thyroid glands, except that nucleotides 1,041 and 1,277 were changed from A to G and from C to T, respectively, 2) expression levels of TSHR in epididymal adipose tissue and in thyroid are similar, and 3) TSH induces lipolysis in isolated rat fat cells.
Using 3T3-L1 preadipocyte and primary cultured rat adipocytes, we also found that TSHR is expressed during lineagespecific differentiation of 3T3-L1 preadipocyte into mature fat cells and that triiodothyronine (T 3 ) stimulates the processes, but conversely, we also found that TSH induces lipolysis and dedifferentiation of mature fat cells (11) (12) (13) . Recently, Gagnon et al. (9) reported that TSH stimulated lipolysis in cultured human differentiated adipocytes and the in vivo effect of recombinant human TSH to raise free fatty acid (FFA) levels in thyroidectomized humans. All of these findings support the hypothesis that TSH works as a lipolytic factor in WAT, but this hypothesis and the in vivo phenotypes of hypo-and hyperthyroidism seem discordant.
Mutant hyt/hyt mice (C.RF-Tshr hyt/hyt mice) are hypothyroid and have severely hypoplastic thyroid glands because of hyt, a mutation in the fourth transmembrane domain of TSHR (19) . This mutation in codon 556 results in a proline-to-leucine substitution and a mutant TSHR that localizes to the plasma membrane and has defective TSH binding and receptor function (10) . The normally reciprocal relationship between thyroid hormone (TH) and TSH is disrupted in these mice; therefore, we reasoned that these mice are a suitable model for studying the role of TSH in adipose tissues. Using hyt/hyt mice and local TSHR gene restoration, we found that TSHR is involved in the regulation of thermogenesis in brown adipose tissue (8) .
In the present study, we restored the functional mouse TSHR gene in WAT of hyt/hyt mice using the plasmid injection combined with electroporation (PICE) technique and then assessed the roles of TSH on lipid metabolism.
MATERIALS AND METHODS

Animals and cells.
All studies were approved by the Animal Research Committee of the University of Yamanashi. C.RF-Tshr hyt/wild mice were obtained from The Jackson Laboratory (Bar Harbor, ME) and bred to generate experimental animals. The mutant mice were kept in a specific pathogen-free mouse room. Twelve-week-old wildtype and mutant male mice were used. The mice did not receive any TH supplementation. Even without treatment, both sexes of Tshr hyt/wild mice and male Tshr hyt/hyt mice are fertile. Tshr hyt/hyt (hyt/hyt) mice were born healthy and developed normally except for being slightly shorter and lighter than the wild-type mice (Table 1) . Total thyroidectomy was carried out to group 4 mice under pentobarbital-induced anesthesia 4 days before the start of the experiment. Sham operation (median incision of the neck, exposure of trachea, and suturing of the skin) was also carried out to mice groups 1-3 ( Table 1) . Levels of TSH, free (f)T 3, and fT4 (thyroxine) before and after the experiment are shown in Table 1 . TH supplementation to the hyt/hyt mice was started from the beginning of the study. To maintain hyt/hyt mice in euthyroid, we bred animals preliminary with food pellets containing various amounts of thyroid extract. We found that 125 ppm of Thyradine powder (Asuka Pharmaceutical, Tokyo, Japan) could keep them in euthyroid. To confirm TSHR genotype, we carried out PCR using tail DNA with the following primers: 5=-GGCAATATCTTCGTCCT-GCTC-3= and 5=-GATGATCTTCAGATAGCAGG-3= (8) . The nucleotide at codon 556, wild type (CCG) or mutant (CTG), was determined by directly sequencing PCR products. At the end point of the experiment, epididymal fat was fixed with 4% paraformaldehyde in phosphate-buffered saline. The specimens were dehydrated with increasing concentrations of ethanol and embedded in paraffin. Sections (5 m) were stained with hematoxylin-eosin. The 293 cell line was purchased from Clontech Laboratories (Palo Alto, CA); transfection of the plasmid into these cells was carried out with the Gene Pulser (Gene Pulser Xcell; Bio-Rad, Tokyo, Japan) at 250 V-750 F.
Gene transfer into epididymal fat tissues by PICE. The construct pCMVP-enhanced green fluoresence protein (EGFP) was generated by inserting a DNA fragment containing cytomegalovirus (CMV) promoter (BglII/BamHI) from pcDNA3.1/Zeo (Invitrogen, Carlsbad, CA) into pEGFP-1 (Clontech Laboratories). Mouse TSHR cDNA was amplified by RT-PCR from the thyroid glands of wild-type C.RF mice, and this cDNA was ligated to pCMVP-EGFP cut with BamHI and EcoRI (pCMVP-mTSHR-EGFP). Plasmid DNA, pEGFP-1, or pCMVP-mTSHR-EGFP was dissolved in 10 l of sterile phosphatebuffered saline (pH 7.4) at a concentration of 1 mg/ml and injected into the left and right side, respectively, of the epididymal fat of hyt/hyt mice using a 27-gauge needle. Electric pulses were delivered using an electric pulse generator (Square Electroporator CUY21; NEPA GENE, Chiba, Japan) with a pair of stainless electrode needles. Two 50-ms pulses of 70 V, followed by two more pulses of the opposite polarity, were administered at a rate of 1 pulse/s. Three weeks after PICE, epididymal fat tissues were resected, sliced (1 mm), and mounted on glass slides. EGFP florescence was observed with a reflection fluorescence microscope (Olympus model IX71).
RT-PCR and quantitative PCR. Messenger RNAs from cultured cells and tissues were prepared using the RNeasy Mini kit (Qiagen, Valencia, CA). RNAs (10 g) were reverse transcribed with Rousassociated virus reverse transcriptase (Takara Bio, Shiga, Japan) at 42°C for 60 min in 50-l mixture in the presence of a random primer. Samples (1 l) of these reverse transcription reactions were used as template for PCR. PCR primers used for mouse TSHR were as follows: sense, 5=-ATCGCGGATCCGAAGTAGCCCAGAGGGTC-CCTTGG-3=; antisense, 5=-GATCAG AATTCCAAGGCTGTTTG-CTTATACTCTTC-3=. Quantitative PCR was carried out with RotorGene Q (Qiagen) using TaqMan probes (Applied Biosystems, Carlsbad, CA) for mouse hormone-sensitive lipase (Mm00495359_m1), mouse triglyceride lipase (Mm00503040_m1), and mouse GAPDH (MA999999_g1). For EGFP, sense 5=-GCAAAC CACTACCTGAG-CAC-3=, antisense 5=-CAGGACCATGTGATCGCG-3=, and probe 5=-/56-FAM/C CTG/ZEN/AGCAAAGACCCCA /3IABkFQ-3= were purchased from Integrated DNA Technologies (San Diego, CA). Each assay was carried out in triplicate, and transcript levels were normalized using GAPDH as reference gene.
Measurement of mouse thyroid functions. fT 4 and fT3 in serum were assayed using the ECLusis system (Roche Diagnostic, Tokyo, Japan). Mouse TSH was assayed using the Rat TSH ELISA kit (AKRTS-010; Shibayagi, Gunma, Japan), using the cross-reactivity of the antibody to rat TSH. Cyclic AMP in the cells was assayed using the commercially available RIA kit (Yamasa Shoyu, Chiba, Japan), and 125 I-TSH binding activities of the cells were assessed using 125 I-bovine TSH (Cosmic, Tokyo, Japan) and the methods described by Mizutori et al. (16) . Blood glucose was measured by the FreeStyle blood glucose monitoring system (Nipro, Tokyo, Japan). Serum insulin was assayed with the Insulin Kit (Morinaga, Yokohama, Japan).
FFA from epididymal fat was measured by the Free Fatty Acid Quantification Kit (BioVision Research Products, Mountain View, CA). Epididymal fat tissues (10 mg) were washed with Hanks' balanced salt solution containing 4% bovine serum albumin two times and were incubated for 45 min at 37°C with or without TSH (7). The increase in FFA was calculated by subtracting the control values (FFA in the absence of TSH).
Statistical analysis. Statistical analysis was carried out using oneway ANOVA and Student's t-test.
RESULTS
Adipose phenotypes of thyroidectomized and hyt/hyt mice.
Using wild-type and hyt/hyt mice, we prepared four groups of mice. Group 1 had normal levels of fT 4 and TSH and competent TSHR (wild-type mice), group 2 had low fT 4 , high TSH, and nonfunctional TSHR (hyt/hyt mice), group 3 had normal fT 4 and TSH and nonfunctional TSHR (hyt/hyt mice supplemented orally with TH), and group 4 had low fT 4 , high TSH, and functional TSHR [thyroidectomized (THYx) mice]. At the start of the experiment, these mice were shorter and lighter than the wild-type mice (Table 1) . After 4 wk, serum-free T 4 of THYx mice (group 4) was low to 0.21 Ϯ 0.09 ng/dl, and serum TSH was high to 73.9 Ϯ 3.0 ng/ml. Levels of free T 4 and TSH in serum from hyt/hyt mice (group 2) were similar to those in THYx mice, showing that the hyt/hyt mice were in a severe hypothyroid state (Table 1 ). The concentration of fT 4 in serum from hyt/hyt mice supplemented with T 4 (group 3) was 1.88 Ϯ 0.10 ng/dl, and that of TSH was 0.88 Ϯ 0.21 ng/ml, indicating that these mice were in an euthyroid state. Thus, adipose tissues of the mice in group 1 had physiological T 4 action and TSH signal, but those of the mice in group 2 had low T 4 action and lacked TSH signal. The mice in group 3 were in an 
Values are means Ϯ SE. TH, thryroid hormone; THYx, thyroidectomized; fT4, free thyroxine; fT3, free triiodothyronine; IRI, immunoreactive insulin. *C.RF-Tshr hyt/hyt mice. †From tip of the nose to base of the tail (cm) at the start of experiment. ‡At the start and the end point of the experiment. euthyroid state but lacked TSH signal. Conversely, the mice in group 4 had low T 4 action but high TSH signal. No significant differences were observed in serum glucose and insulin levels in these four groups of mice (Table 1) . Catecholamine levels were not measured, and any effect they may have had on lipolysis is not known. Macroscopic features of epididymal fat from the wild-type, hyt/hyt, THYx, and hyt/hyt mice supplemented with TH are shown in Fig. 1 . Notably, epididymal fat volume in hyt/hyt mice, which had very low levels of fT 4 in serum (0.15 Ϯ 0.09 ng/dl), was slightly small but not very different from that in wild-type mice (Fig. 1, A and B) . The oral TH supplements given to hyt/hyt mice further increased fat volume in these mice (Fig. 1C) , which was almost indistinguishable from that in wild-type mice. In contrast, fat volume in THYx mice was much lower, and the tissue was very atrophic (Fig. 1D) . Microscopically, compared with hyt/hyt mice, adipocytes in epididymal fat from THYx mice were small and irregularly shaped (Fig. 1H) . The mean maximal diameter of adipocytes from THYx mice (79 Ϯ 2.8 m) was significantly smaller than that of hyt/hyt mice (121 Ϯ 2.2 m) ( Fig. 2A) . Mean diameter of the hyt/hyt mice was also significantly smaller than that of wild-type mice (150 Ϯ 4.7 m), but the mean diameter of adipocytes in hyt/hyt mice given TH supplements was similar to that in wild-type mice.
Since hyt/hyt mice were shorter and lighter than wild-type mice, we estimated epididymal fat (mg)/total body wt (g) (F/B) ratio of these mice at the end of the experiment (Fig. 2B) . Although both THYx and hyt/hyt mice were in a severe hypothyroid state, F/B ratio of the THYx mice was much smaller than that of the hyt/hyt mice. Moreover, the F/B ratio of hyt/hyt mice was smaller than that of the wild-type mice, although cell size following TH supplement restored it to the wild-type level (Fig. 2B) . Other fat pads, e.g., perirenal and visceral fat tissues, were also affected like epididymal fat pads in these four groups of mice ( Table 1) .
PICE of a functional TSHR gene into epididymal fat of the hyt/hyt and the wild-type mice.
To study direct roles of TSH in WAT, we transferred a functional mouse TSHR gene into the epididymal fat tissues using PICE. To confirm successful gene transfer and expression of TSHR in WAT, we constructed plasmid that encoded a mouse TSHR tagged with EGFP at the COOH terminus (pCMVP-mTSHR-EGFP).
At first, we transfected pCMVP-mTSHR-EGFP into 293 cells and studied cAMP responsiveness to TSH and 125 I-TSHbinding activity of the cells. TSH dose-dependently increased cAMP production (Fig. 3A) ; moreover, we observed highaffinity TSH-binding activity in 293 cells expressing mTSHR-EGFP (Ka ϭ 30 U/ml). No specific binding was observed in 293 cells transfected with the control plasmid pEGFP (Fig. 3B) . Fig. 2 . Fat cell diameter and epididymal fat/body weight ratio. A: maximal fat cell diameters. Tissue sections from the wild-type (W), hyt/hyt (hyt), hyt/hyt mice supplemented with thyroid hormone (hyt ϩ TH), and thyroidectomized (THYx) wild-type mice were stained with hematoxylin-eosin and then photographed. A mean of 500 cells from each group was measured. B: the mean epididymal fat (mg)/total body weight (g) ratio of each group of mice was determined. W, n ϭ 7; hyt, n ϭ 6; hyt ϩ TH, n ϭ 6; THYx, n ϭ 5. Thus, as Latif et al. (15) reported previously, eGFP-tagged TSHR retained receptor functions. Figure 3C shows EGFP fluorescence in epididymal fat from hyt/hyt mice with the TSHR-EGFP gene. After 48 h of electroporation, green fluorescence was evident in adipocytes of the injected site. Since the tissues naturally expressed mutated TSHR, we evaluated electroporation efficiency of DNA into the epididymal fat by measuring EGFP gene with quantitative PCR. On the basis of our findings, we estimate that (3.0 Ϯ 0.26) ϫ 10 6 copies of the plasmid at 48 h after PICE and (6.82 Ϯ 0.79) ϫ 10 5 copies of the plasmid at the end of the experiment were transferred per milligram of tissue (n ϭ 3). Figure 4 , A and B, shows macroscopic views of epididymal fat from hyt/hyt (n ϭ 5) and wild-type (n ϭ 5) mice after 3 wk of PICE. For all mice, epididymal fat on the right was injected with 10 g of pCMVP-mTSHR-EGFP, and fat on the left was injected with same amount of the control plasmid pEGFP. Epididymal fat from the right side of the hyt/hyt mice was small and atrophic relative to that from the left side (Fig. 4A) ; in contrast, there was little difference between epididymal fat from the right and the left sides of the wild-type mice (Fig. 4B) . The cAMP levels in epididymal fat from the right and left sides were measured; there was no significant difference between the sides in wild-type mice, but the cAMP levels in right (TSHRcontaining) epididymal fat of hyt/hyt mice were 2.7-fold higher than those in the tissue from the left (control) side (2.7 Ϯ 0.36; Fig. 4C ). The ratio of the mass of fat tissue injected with TSHR gene to the weight of fat tissues injected with control plasmid was lower in hyt/hyt mice than in wild-type mice (0.6 Ϯ 0.08 and 0.94 Ϯ 0.14, respectively; Fig. 4D) . Microscopically, the cells of epididymal fat from the right side of hyt/hyt mice were small and irregular like the cells of epididymal fat from THYx mice. The ratio of the mean maximal diameter of right side fat cells to the mean maximal diameter of left side fat cells in the hyt/hyt mice was decreased to 0.52 Ϯ 0.18, whereas that in wild-type mice was 1.1 Ϯ 0.03 (Fig. 4E) . Figure 4F shows the release of FFA in response to TSH from the epididymal fat from the wild-type and hyt/hyt mice.
TSH dose-dependently increased FFA in the medium from epididymal fat tissues from the left (GFP gene transferred) and the right (TSHR-EGFP gene transferred) sides of the wild-type mice. The increase in FFA from the right side tended to be larger than that from the left side of epididymal fat tissues but was not significant. No significant increase in FFA was observesd from the left (GFP gene transferred) epididymal fat tissues from hyt/hyt mice by 10 U/ml of TSH. However, 100 U/ml of TSH increased FFA significantly in the medium from the right (TSHR-EGFP gene transferred) sides of the hyt/hyt mice. These results suggest that high concentrations of TSH play an important role in FFA release from TSHR-EGFP gene-transferred epididymal fat of hyt/hyt mice.
We further studied the effects of PICE-mediated TSHR gene transfer on the expression levels of lipolytic enzyme genes such as hormone-sensitive lipase and triglyceride lipase. Quantitative PCR revealed that that the level of hormone-sensitive lipase mRNA in epididymal fat from the right (TSHR-containing) side of hyt/hyt mice was about twofold (2.2 Ϯ 0.16) higher than that from the left (control) side (Fig. 4F) . In contrast, no significant difference in the expression levels of triglyceride lipase mRNA was observed between the right (TSHR-containing) and left (control) sides in either hyt/hyt mice or wild-type mice (Fig. 4G) .
DISCUSSION
It has been thought that hypothyroidism is associated with low metabolic rate and positive caloric balance, leading to slight fat gain in human (14) . However, in the course of our previous studies (8), we noticed that body weight of THYx mice was lighter than that of hyt/hyt mice, leading us to study the roles of TSH on fat metabolism.
Adipocyte lipolysis and lipogenesis are complex processes that are tightly regulated via integration of multiple hormonal and biochemical signals. Many substances regulate cAMP levels and thereby lipolysis and are balanced by inhibitory factors such as adenosine and insulin (3) .
Ever since the discovery that TSH induces lipolysis in white adipose tissue (17) , TSH has been a candidate lipolytic factor. Our subsequent studies using cultured preadipocyte (3T3-L1) or primary cultured rodent adipose cells support this hypothesis (11-13) but do not concur with previous in vivo findings that hypothyroidism is associated with obesity and hyperthyroidism with weight loss. However, these in vivo phenotypes were observed mainly in animals treated with antithyroid drugs or thyroidectomized animals, where serum T 4 was low and serum TSH high. Therefore, both serum T 4 and serum TSH might affect lipid metabolism in white adipose tissue, and distinguishing the effects of each is difficult.
Mutant hyt/hyt mice, which have a mutated TSHR that leads to a loss of TSHR function, were used in the present study. Adipocytes from thyroidectomized mice were much smaller than those from hyt/hyt mice, and fat volume was also much lower in thyroidectomized mice. These findings clearly indicated that TSH worked as a lipolytic factor. Conversely, maintenance of the euthyroid state in hyt/hyt mice with TH supplements indicated that the F/B ratio returned to that of wild-type mice, meaning that TH worked as a lipogenic factor. Interestingly, epididymal fat in hyt/hyt mice was not as atrophic as that in thyroidectomized mice. Although serum T 4 was low in hyt/hyt mice, lipid synthesis may outweigh lipid degradation in these mice because the TSH signal is absent. The results of PICE-mediated transfer of TSHR and control genes in hyt/hyt mice, which had low T 4 and high TSH, demonstrated clearly that expression of functional TSHR resulted in an increase in the expression of hormone-sensitive lipase gene and a decrease in fat volume, indicating that TSH works as lipolytic factor in white adipose tissue in vivo.
Very recently, Elgadi et al. (5) developed an adipose tissuespecific TSHR-knockout mouse strain using the Cre-LoxP recombination system. Although the maximum lipolytic response of adipocytes to TSH was similar in wild-type and knockout mice, probably because of incomplete removal of TSHR from adipose tissue, their report indicates that adipocyte size increased in knockout animals, which is consistent in part with our data.
Hypothyroid patients have low T 4 and high TSH. Patients with Graves' disease have high serum T 4 and TSHR autoantibody, which binds to TSHR and increases cAMP production (4) . Therefore, the present data may clarify the mechanism of body weight change and energy balance not only in hypothyroidism but also in hyperthyroidism, especially in Graves' disease.
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